1 INTRODUCTION 32
1.1 OBJECTIVES OF THE STUDY 32
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 33
1.3 MARKET SCOPE 33
1.3.1 MARKETS COVERED 33
FIGURE 1 BIOPROCESS CONTAINERS MARKET SEGMENTATION 33
1.3.2 YEARS CONSIDERED FOR THE STUDY 34
1.4 CURRENCY 34
1.5 LIMITATIONS 34
1.6 STAKEHOLDERS 35
1.7 SUMMARY OF CHANGES 35

2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DESIGN 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 37
2.1.1.1 Secondary sources: Bioprocess containers market 38
2.1.2 PRIMARY DATA 38
FIGURE 3 BREAKDOWN OF PRIMARIES: BIOPROCESS CONTAINERS MARKET 39
2.1.2.1 Key data from primary sources 39
2.2 MARKET SIZE ESTIMATION 40
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 40
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 41
FIGURE 5 MARKET SIZE ESTIMATION: BIOPROCESS CONTAINERS MARKET 41
2.2.2 PRIMARY RESEARCH VALIDATION 41
FIGURE 6 BIOPROCESS CONTAINERS MARKET: CAGR PROJECTIONS 42
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 43
FIGURE 7 DATA TRIANGULATION METHODOLOGY 43
2.4 ASSUMPTIONS FOR THE STUDY 44

3 EXECUTIVE SUMMARY 45
FIGURE 8 BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 45
FIGURE 9 BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 46
FIGURE 10 BIOPROCESS CONTAINERS MARKET SHARE, BY END USER, 2020 47
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE BIOPROCESS CONTAINERS MARKET 48

4 PREMIUM INSIGHTS 49
4.1 BIOPROCESS CONTAINERS MARKET OVERVIEW 49
FIGURE 12 GROWING BIOLOGICS MARKET TO DRIVE MARKET GROWTH 49
4.2 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY TYPE & COUNTRY (2020) 50
FIGURE 13 2D BIOPROCESS CONTAINERS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020 50
4.3 BIOPROCESS CONTAINERS MARKET, BY END USER 51
FIGURE 14 CMOS & CROS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 51

5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
FIGURE 15 BIOPROCESS CONTAINERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
5.2.1 DRIVERS 53
5.2.1.1 Growing biologics market 53
FIGURE 16 GLOBAL BIOLOGICS MARKET, 2014?2023 (USD BILLION) 53
5.2.1.2 Affordability and sustainability of single-use bioprocess technologies 54
FIGURE 17 ADOPTION OF SINGLE-USE PRODUCTS IN BIOPHARMACEUTICAL MANUFACTURING, 2019 55
5.2.1.3 Rising biopharmaceutical R&D 55
FIGURE 18 GLOBAL R&D INVESTMENTS BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2010?2025 (USD BILLION) 56
5.2.2 RESTRAINTS 56
5.2.2.1 Issues related to leachables and extractables 56
TABLE 1 TYPICAL EXTRACTABLES FOR ACCEPTABLE MATERIALS USED IN DISPOSABLE BIOPROCESS MANUFACTURING SYSTEMS 57
5.2.3 OPPORTUNITIES 57
5.2.3.1 Emerging countries 57
5.2.3.2 Patent expiry of biologics 58
TABLE 2 US: BIOLOGICS GOING OFF-PATENT DURING 2018-2025 58
5.2.4 CHALLENGES 58
5.2.4.1 Waste disposal 58
TABLE 3 COMPARISON OF DISPOSAL OPTIONS FOR SINGLE-USE ASSEMBLY PRODUCTS 59
5.3 IMPACT OF COVID-19 ON THE BIOPROCESS CONTAINERS MARKET 59
FIGURE 19 COVID-19 IMPACT ON THE BIOPROCESS CONTAINERS MARKET, 2019?2021, (USD MILLION) 59

6 BIOPROCESS CONTAINERS MARKET, BY TYPE 61
6.1 INTRODUCTION 62
TABLE 4 BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION) 62
TABLE 5 BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION) 63
6.2 2D BIOPROCESS CONTAINERS 63
6.2.1 WIDE USE OF 2D BAGS IN BIOPRODUCTION APPLICATIONS TO DRIVE MARKET GROWTH 63
TABLE 6 EXAMPLES OF 2D BIOPROCESS CONTAINERS AVAILABLE IN THE MARKET 64
TABLE 7 2D BIOPROCESS CONTAINERS MARKET, BY REGION, 2017-2020 (USD MILLION) 64
TABLE 8 2D BIOPROCESS CONTAINERS MARKET, BY REGION, 2021-2026 (USD MILLION) 64
TABLE 9 NORTH AMERICA: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION) 65
TABLE 10 NORTH AMERICA: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION) 65
TABLE 11 EUROPE: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION) 65
TABLE 12 EUROPE: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION) 66
TABLE 13 ASIA PACIFIC: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION) 66
TABLE 14 ASIA PACIFIC: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION) 67
6.3 3D BIOPROCESS CONTAINERS 67
6.3.1 SIGNIFICANT REDUCTIONS IN LABOR COSTS AND FASTER BATCH TURNAROUND ACHIEVED USING THESE CONTAINERS TO PROPEL MARKET GROWTH 67
TABLE 15 EXAMPLES OF 3D BIOPROCESS CONTAINERS AVAILABLE IN THE MARKET 67
TABLE 16 3D BIOPROCESS CONTAINERS MARKET, BY REGION, 2017-2020 (USD MILLION) 68
TABLE 17 3D BIOPROCESS CONTAINERS MARKET, BY REGION, 2021-2026 (USD MILLION) 68
TABLE 18 NORTH AMERICA: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION) 68
TABLE 19 NORTH AMERICA: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION) 69
TABLE 20 EUROPE: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION) 69
TABLE 21 EUROPE: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION) 70
TABLE 22 ASIA PACIFIC: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION) 70
TABLE 23 ASIA PACIFIC: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION) 71
6.4 OTHER CONTAINERS & ACCESSORIES 71
TABLE 24 OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY REGION, 2017-2020 (USD MILLION) 71
TABLE 25 OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY REGION, 2021-2026 (USD MILLION) 72
TABLE 26 NORTH AMERICA: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY COUNTRY, 2017-2020 (USD MILLION) 72
TABLE 27 NORTH AMERICA: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY COUNTRY, 2021-2026 (USD MILLION) 72
TABLE 28 EUROPE: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY COUNTRY, 2017-2020 (USD MILLION) 73
TABLE 29 EUROPE: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY COUNTRY, 2021-2026 (USD MILLION) 73
TABLE 30 ASIA PACIFIC: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY COUNTRY, 2017-2020 (USD MILLION) 74
TABLE 31 ASIA PACIFIC: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY COUNTRY, 2021-2026 (USD MILLION) 74

7 BIOPROCESS CONTAINERS MARKET, BY APPLICATION 75
7.1 INTRODUCTION 76
TABLE 32 BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION) 76
TABLE 33 BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION) 77
7.2 UPSTREAM PROCESSES 77
7.2.1 FREQUENT USE OF BIOPROCESS CONTAINERS DURING FERMENTATION AND CULTURE MEDIA PROCESSING IS A MAJOR FACTOR DRIVING THE MARKET 77
TABLE 34 BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY REGION, 2017-2020 (USD MILLION) 78
TABLE 35 BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY REGION, 2021-2026 (USD MILLION) 78
TABLE 36 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2017-2020 (USD MILLION) 78
TABLE 37 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2021-2026 (USD MILLION) 79
TABLE 38 EUROPE: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2017-2020 (USD MILLION) 79
TABLE 39 EUROPE: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2021-2026 (USD MILLION) 80
TABLE 40 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2017-2020 (USD MILLION) 80
TABLE 41 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2021-2026 (USD MILLION) 81
7.3 DOWNSTREAM PROCESSES 81
7.3.1 WIDE USAGE OF BPC ASSEMBLY FOR PURIFICATION APPLICATIONS TO DRIVE MARKET GROWTH 81
TABLE 42 BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY REGION, 2017-2020 (USD MILLION) 82
TABLE 43 BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY REGION, 2021-2026 (USD MILLION) 82
TABLE 44 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2017-2020 (USD MILLION) 82
TABLE 45 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2021-2026 (USD MILLION) 83
TABLE 46 EUROPE: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2017-2020 (USD MILLION) 83
TABLE 47 EUROPE: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2021-2026 (USD MILLION) 84
TABLE 48 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2017-2020 (USD MILLION) 84
TABLE 49 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2021-2026 (USD MILLION) 85
7.4 PROCESS DEVELOPMENT 85
7.4.1 REDUCED RISK OF CROSS-CONTAMINATION AND REDUCED OPERATIONAL COSTS MAKE BPCS THE MOST PREFERRED SOLUTION FOR PROCESS DEVELOPMENT 85
TABLE 50 BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2017-2020 (USD MILLION) 86
TABLE 51 BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2021-2026 (USD MILLION) 86
TABLE 52 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2017-2020 (USD MILLION) 86
TABLE 53 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021-2026 (USD MILLION) 87
TABLE 54 EUROPE: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2017-2020 (USD MILLION) 87
TABLE 55 EUROPE: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021-2026 (USD MILLION) 88
TABLE 56 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2017-2020 (USD MILLION) 88
TABLE 57 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021-2026 (USD MILLION) 89

8 BIOPROCESS CONTAINERS MARKET, BY END USER 90
8.1 INTRODUCTION 91
TABLE 58 BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION) 91
TABLE 59 BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION) 91
8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 92
8.2.1 BPCS HAVE FOUND WIDE USE IN BIOPHARMACEUTICAL MANUFACTURING DUE TO THEIR COST-EFFECTIVENESS 92
TABLE 60 BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2017-2020 (USD MILLION) 92
TABLE 61 BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021-2026 (USD MILLION) 93
TABLE 62 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017-2020 (USD MILLION) 93
TABLE 63 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2026 (USD MILLION) 93
TABLE 64 EUROPE: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017-2020 (USD MILLION) 94
TABLE 65 EUROPE: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2026 (USD MILLION) 94
TABLE 66 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017-2020 (USD MILLION) 95
TABLE 67 APAC: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2026 (USD MILLION) 95
8.3 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS 96
8.3.1 INCREASING OUTSOURCING OF R&D SERVICES BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO SUPPORT MARKET GROWTH 96
TABLE 68 BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY REGION, 2017-2020 (USD MILLION) 96
TABLE 69 BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY REGION, 2021-2026 (USD MILLION) 97
TABLE 70 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY COUNTRY, 2017-2020 (USD MILLION) 97
TABLE 71 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY COUNTRY, 2021-2026 (USD MILLION) 97
TABLE 72 EUROPE: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY COUNTRY, 2017-2020 (USD MILLION) 98
TABLE 73 EUROPE: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY COUNTRY, 2021-2026 (USD MILLION) 98
TABLE 74 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY COUNTRY, 2017-2020 (USD MILLION) 99
TABLE 75 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY COUNTRY, 2021-2026 (USD MILLION) 99
8.4 ACADEMIC & RESEARCH INSTITUTES 100
8.4.1 GROWING COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES TO DRIVE MARKET GROWTH 100
TABLE 76 BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017-2020 (USD MILLION) 100
TABLE 77 BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2026 (USD MILLION) 100
TABLE 78 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017-2020 (USD MILLION) 101
TABLE 79 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2026 (USD MILLION) 101
TABLE 80 EUROPE: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017-2020 (USD MILLION) 101
TABLE 81 EUROPE: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2026 (USD MILLION) 102
TABLE 82 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017-2020 (USD MILLION) 102
TABLE 83 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2026 (USD MILLION) 103

9 BIOPROCESS CONTAINERS MARKET, BY REGION 104
9.1 INTRODUCTION 105
TABLE 84 BIOPROCESS CONTAINERS MARKET, BY REGION, 2017-2020 (USD MILLION) 105
TABLE 85 BIOPROCESS CONTAINERS MARKET, BY REGION, 2021-2026 (USD MILLION) 105
9.2 NORTH AMERICA 106
FIGURE 20 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET SNAPSHOT 107
TABLE 86 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION) 108
TABLE 87 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION) 108
TABLE 88 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION) 108
TABLE 89 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION) 109
TABLE 90 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION) 109
TABLE 91 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION) 109
TABLE 92 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION) 110
TABLE 93 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION) 110
9.2.1 US 110
9.2.1.1 The US dominates the North American bioprocess containers market 110
TABLE 94 US: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION) 111
TABLE 95 US: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION) 111
TABLE 96 US: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION) 112
TABLE 97 US: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION) 112
TABLE 98 US: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION) 112
TABLE 99 US: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION) 113
9.2.2 CANADA 113
9.2.2.1 Growing number of biopharmaceutical manufacturing facilities is supporting the growth of the market in Canada 113
FIGURE 21 CANADA: BIOLOGICS SALES, 2009-2018 (USD BILLION) 113
TABLE 100 CANADA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION) 114
TABLE 101 CANADA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION) 114
TABLE 102 CANADA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION) 114
TABLE 103 CANADA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION) 115
TABLE 104 CANADA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION) 115
TABLE 105 CANADA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION) 115
9.3 EUROPE 116
TABLE 106 EUROPE: BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION) 116
TABLE 107 EUROPE: BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION) 117
TABLE 108 EUROPE: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION) 117
TABLE 109 EUROPE: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION) 117
TABLE 110 EUROPE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION) 118
TABLE 111 EUROPE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION) 118
TABLE 112 EUROPE: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION) 118
TABLE 113 EUROPE: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION) 119
9.3.1 GERMANY 119
9.3.1.1 Increasing adoption of single-use bioprocess systems by biopharmaceutical and CDMO companies to drive market growth 119
TABLE 114 GERMANY: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION) 120
TABLE 115 GERMANY: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION) 120
TABLE 116 GERMANY: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION) 120
TABLE 117 GERMANY: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION) 121
TABLE 118 GERMANY: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION) 121
TABLE 119 GERMANY: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION) 121
9.3.2 UK 122
9.3.2.1 Rising government support for biotechnology companies to propel the demand for advanced technologies in the UK 122
TABLE 120 UK: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION) 122
TABLE 121 UK: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION) 123
TABLE 122 UK: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION) 123
TABLE 123 UK: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION) 123
TABLE 124 UK: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION) 124
TABLE 125 UK: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION) 124
9.3.3 FRANCE 124
9.3.3.1 Increasing investments in life science R&D infrastructure development to support market growth 124
TABLE 126 FRANCE: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION) 125
TABLE 127 FRANCE: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION) 125
TABLE 128 FRANCE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION) 125
TABLE 129 FRANCE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION) 126
TABLE 130 FRANCE: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION) 126
TABLE 131 FRANCE: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION) 126
9.3.4 ITALY 127
9.3.4.1 High R&D investments in the field of biotechnology research to support market growth in Italy 127
TABLE 132 ITALY: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION) 127
TABLE 133 ITALY: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION) 127
TABLE 134 ITALY: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION) 128
TABLE 135 ITALY: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION) 128
TABLE 136 ITALY: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION) 128
TABLE 137 ITALY: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION) 129
9.3.5 ROE 129
TABLE 138 ROE: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION) 129
TABLE 139 ROE: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION) 130
TABLE 140 ROE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION) 130
TABLE 141 ROE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION) 130
TABLE 142 ROE: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION) 131
TABLE 143 ROE: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION) 131
9.4 ASIA PACIFIC 131
FIGURE 22 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET SNAPSHOT 132
TABLE 144 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION) 133
TABLE 145 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION) 133
TABLE 146 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION) 134
TABLE 147 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION) 134
TABLE 148 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION) 134
TABLE 149 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION) 135
TABLE 150 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION) 135
TABLE 151 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION) 135
9.4.1 CHINA 136
9.4.1.1 China to witness the highest growth in the global bioprocess containers market 136
TABLE 152 CHINA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION) 136
TABLE 153 CHINA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION) 137
TABLE 154 CHINA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION) 137
TABLE 155 CHINA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION) 137
TABLE 156 CHINA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION) 138
TABLE 157 CHINA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION) 138
9.4.2 SOUTH KOREA 138
9.4.2.1 Government support to boost the production of biological to drive market growth 138
TABLE 158 SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION) 139
TABLE 159 SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION) 139
TABLE 160 SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION) 140
TABLE 161 SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION) 140
TABLE 162 SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION) 140
TABLE 163 SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION) 141
9.4.3 JAPAN 141
9.4.3.1 Expansion of biopharmaceutical manufacturing plants in Japan has created growth opportunities for BPC companies 141
TABLE 164 JAPAN: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION) 142
TABLE 165 JAPAN: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION) 142
TABLE 166 JAPAN: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION) 142
TABLE 167 JAPAN: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION) 143
TABLE 168 JAPAN: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION) 143
TABLE 169 JAPAN: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION) 143
9.4.4 INDIA 144
9.4.4.1 COVID-19 vaccines production has created significant demand for single-use bioprocess containers 144
TABLE 170 INDIA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION) 145
TABLE 171 INDIA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION) 145
TABLE 172 INDIA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION) 145
TABLE 173 INDIA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION) 146
TABLE 174 INDIA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION) 146
TABLE 175 INDIA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION) 146
9.4.5 ROAPAC 147
TABLE 176 ROAPAC: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION) 147
TABLE 177 ROAPAC: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION) 148
TABLE 178 ROAPAC: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION) 148
TABLE 179 ROAPAC: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION) 148
TABLE 180 ROAPAC: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION) 149
TABLE 181 ROAPAC: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION) 149
9.5 REST OF THE WORLD 149
TABLE 182 ROW: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION) 150
TABLE 183 ROW: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION) 150
TABLE 184 ROW: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION) 151
TABLE 185 ROW: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION) 151
TABLE 186 ROW: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION) 151
TABLE 187 ROW: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION) 152

10 COMPETITIVE LANDSCAPE 153
10.1 INTRODUCTION 153
10.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 153
FIGURE 23 BIOPROCESS CONTAINERS MARKET: RIGHT-TO-WIN STRATEGIES ADOPTED BY KEY PLAYERS 154
10.3 MARKET SHARE ANALYSIS 155
FIGURE 24 BIOPROCESS CONTAINERS: MARKET SHARE ANALYSIS, 2020 155
10.4 COMPANY EVALUATION QUADRANT 156
FIGURE 25 BIOPROCESS CONTAINERS MARKET: COMPANY EVALUATION MATRIX, 2020 156
10.4.1 STARS 156
10.4.2 PERVASIVE PLAYERS 156
10.4.3 EMERGING LEADERS 157
10.4.4 PARTICIPANTS 157
10.5 COMPETITIVE SCENARIO 157
10.5.1 DEALS 157
TABLE 188 BIOPROCESS CONTAINERS MARKET: DEALS, JANUARY 2018-MAY 2021 157
10.5.2 OTHER DEVELOPMENTS 159

11 COMPANY PROFILES 160
11.1 KEY COMPANIES 160
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 11.1.1 SARTORIUS STEDIM BIOTECH 160
TABLE 189 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 160
FIGURE 26 SARTORIUS STEDIM BIOTECH: COMPANY SNAPSHOT (2020) 161
TABLE 190 SARTORIUS STEDIM BIOTECH: PRODUCT OFFERINGS 161
TABLE 191 SARTORIUS STEDIM BIOTECH: DEALS 162
TABLE 192 SARTORIUS STEDIM BIOTECH: OTHER DEVELOPMENTS 162
11.1.2 THERMO FISHER SCIENTIFIC INC. 164
TABLE 193 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 164
FIGURE 27 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020) 165
TABLE 194 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS 165
TABLE 195 THERMO FISHER SCIENTIFIC INC.: DEALS 166
TABLE 196 THERMO FISHER SCIENTIFIC INC.: OTHER DEVELOPMENTS 167
11.1.3 DANAHER CORPORATION 169
TABLE 197 DANAHER CORPORATION: BUSINESS OVERVIEW 169
FIGURE 28 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 170
TABLE 198 DANAHER CORPORATION: PRODUCT OFFERINGS 171
TABLE 199 DANAHER CORPORATION: DEALS 171
TABLE 200 DANAHER CORPORATION: OTHER DEVELOPMENTS 173
11.1.4 MERCK KGAA 175
TABLE 201 MERCK KGAA: BUSINESS OVERVIEW 175
FIGURE 29 MERCK KGAA: COMPANY SNAPSHOT (2020) 176
TABLE 202 MERCK KGAA: PRODUCT OFFERINGS 176
TABLE 203 MERCK KGAA: OTHER DEVELOPMENTS 177
11.1.5 SAINT-GOBAIN 178
TABLE 204 SAINT-GOBAIN: BUSINESS OVERVIEW 178
FIGURE 30 SAINT-GOBAIN: COMPANY SNAPSHOT (2020) 179
TABLE 205 SAINT-GOBAIN: PRODUCT OFFERINGS 179
TABLE 206 SAINT-GOBAIN: DEALS 180
TABLE 207 SAINT-GOBAIN: OTHER DEVELOPMENTS 181
11.1.6 AVANTOR, INC. 182
TABLE 208 AVANTOR, INC.: BUSINESS OVERVIEW 182
FIGURE 31 AVANTOR, INC.: COMPANY SNAPSHOT (2020) 183
TABLE 209 AVANTOR, INC.: PRODUCT OFFERINGS 183
TABLE 210 AVANTOR, INC.: DEALS 184
TABLE 211 AVANTOR, INC.: OTHER DEVELOPMENTS 184
11.1.7 PARKER HANNIFIN CORPORATION 185
TABLE 212 PARKER HANNIFIN CORPORATION: BUSINESS OVERVIEW 185
FIGURE 32 PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2020) 186
TABLE 213 PARKER HANNIFIN: PRODUCT OFFERINGS 186
TABLE 214 PARKER HANNIFIN: OTHER DEVELOPMENTS 187
11.1.8 CORNING INCORPORATED 188
TABLE 215 CORNING INCORPORATED: BUSINESS OVERVIEW 188
FIGURE 33 CORNING INCORPORATED: COMPANY SNAPSHOT (2020) 189
TABLE 216 CORNING INCORPORATED: PRODUCT OFFERINGS 190
11.1.9 ENTEGRIS, INC. 191
TABLE 217 ENTEGRIS, INC.: BUSINESS OVERVIEW 191
FIGURE 34 ENTEGRIS, INC.: COMPANY SNAPSHOT (2020) 192
TABLE 218 ENTEGRIS, INC.: PRODUCT OFFERINGS 192
TABLE 219 ENTEGRIS, INC.: DEALS 193
TABLE 220 ENTEGRIS, INC.: OTHER DEVELOPMENTS 193
11.1.10 MEISSNER FILTRATION PRODUCTS, INC. 194
TABLE 221 MEISSNER FILTRATION PRODUCTS, INC.: BUSINESS OVERVIEW 194
TABLE 222 MEISSNER FILTRATION PRODUCTS, INC.: PRODUCT OFFERINGS 194
11.1.11 LONZA AG 195
TABLE 223 LONZA AG: BUSINESS OVERVIEW 195
FIGURE 35 LONZA AG: COMPANY SNAPSHOT (2020) 196
TABLE 224 LONZA AG: PRODUCT OFFERINGS 196
11.1.12 ANTYLIA SCIENTIFIC 197
TABLE 225 ANTYLIA SCIENTIFIC: BUSINESS OVERVIEW 197
TABLE 226 ANTYLIA SCIENTIFIC: PRODUCT OFFERINGS 197
11.1.13 FLEXBIOSYS INC. 198
TABLE 227 FLEXBIOSYS INC.: BUSINESS OVERVIEW 198
TABLE 228 FLEXBIOSYS INC.: PRODUCT OFFERINGS 198
11.1.14 MICHELIN GROUP 199
TABLE 229 MICHELIN GROUP: BUSINESS OVERVIEW 199
TABLE 230 MICHELIN GROUP: PRODUCT OFFERINGS 199
TABLE 231 MICHELIN GROUP: PRODUCT APPROVALS 200
TABLE 232 MICHELIN GROUP: DEALS 200
11.1.15 ABEC, INC. 201
TABLE 233 ABEC, INC.: BUSINESS OVERVIEW 201
TABLE 234 ABEC, INC.: PRODUCT OFFERINGS 201
TABLE 235 ABEC, INC.: DEALS 202
TABLE 236 ABEC, INC.: OTHER DEVELOPMENTS 203
11.1.16 CELLEXUS 204
TABLE 237 CELLEXUS: BUSINESS OVERVIEW 204
TABLE 238 CELLEXUS: PRODUCT OFFERINGS 204
TABLE 239 CELLEXUS: DEALS 204
11.2 OTHER COMPANIES 205
11.2.1 KEOFITT A/S 205
TABLE 240 KEOFITT A/S: COMPANY OVERVIEW 205
11.2.2 FUJIMORI KOGYO CO., LTD. 205
TABLE 241 FUJIMORI KOGYO CO., LTD.: COMPANY OVERVIEW 205
11.2.3 CESCO BIOENGINEERING CO., LTD. 206
TABLE 242 CESCO BIOENGINEERING CO., LTD.: COMPANY OVERVIEW 206
11.2.4 SOLIDA BIOTECH GMBH 206
TABLE 243 SOLIDA BIOTECH GMBH: COMPANY OVERVIEW 206
11.2.5 SATAKE CHEMICAL EQUIPMENT MFG., LTD. 207
TABLE 244 SATAKE CHEMICAL EQUIPMENT MFG., LTD.: COMPANY OVERVIEW 207
11.2.6 STOBBE PHARMA GMBH 207
TABLE 245 STOBBE PHARMA GMBH: COMPANY OVERVIEW 207
11.2.7 CELLTAINER BIOTECH BV 208
TABLE 246 CELLTAINER BIOTECH BV: COMPANY OVERVIEW 208
11.2.8 FOXX LIFE SCIENCES 208
TABLE 247 FOXX LIFE SCIENCES: COMPANY OVERVIEW 208
11.2.9 SHANGHAI LEPURE BIOTECH CO., LTD. 209
TABLE 248 SHANGHAI LEPURE BIOTECH CO., LTD.: COMPANY OVERVIEW 209
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 12 APPENDIX 210
12.1 DISCUSSION GUIDE 210
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 212
12.3 AVAILABLE CUSTOMIZATIONS 214
12.4 RELATED REPORTS 215
12.5 AUTHOR DETAILS 216